Healthy Living

The Continued Journey to Finding a Cure for Celiac Disease

TIMP-Gliadin: In its early phases, but already promising

Little is known about this, but it is being researched by two companies: (1) Takeda Pharmaceuticals International and (2) Cour Pharmaceutical Development Co. A spokesperson from Takeda has said that it is still too early to announce anything about their tests or when they can divulge any definite result. Of note, however, is the fact that Dr. Daniel Leffler, one of the best researchers focusing on celiac disease, has joined the U.S. Takeda team as the one in charge of clinical science gastroenterology.